COMS

Calendar of upcoming scientific conferences

Home | Conference Management System | Conference Listings | Advertise | Contact | About
German French English
You are in: HomeConference ListingsHealthcare/Medicine → Pharmacology and Drug Development
2nd annual Lyophilisation conference on 7-8 July 2014, London

Conference Management Software

Our Conference Management Software (COMS) can be used for online:

  • registration
  • payment
  • paper submission
  • review process
  • paper selection
  • production of the book of abstracts

Read more ...
Try our demo online

Conferences and Meetings on Pharmacology and Drug Development

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.BWK2014 — Biologics World Korea 2014
 Dates 22 Apr 2014 → 24 Apr 2014
[ID=590298] Go to top of page
 LocationSeoul, South Korea
 Abstract Biologics World Korea has established itself as the ONLY and MOST targeted biologics and biosimilars focused platform in Korea that brings together Korean and international biopharma leaders, innovative biotechs, and technocrats to convene and discuss on strategies, latest technologies and best practices.
 Topics biologics conferences in Korea, biologics industry Korea
 Weblink http://www.imapac.com/index.php?page=BiologicsWorldKorea2014
 Contact Natasha Jiandani; Phone: [(+65-6493-1871)]; Email: natasha.jiandani@imapac.com
  
2.The 3rd Global Clinical Trials Outsourcing Summit
 Dates 23 Apr 2014 → 24 Apr 2014
[ID=593192] Go to top of page
 LocationSeoul, South Korea
 Abstract Each year 150 people come to Seoul, South Korea to learn from an international speaker panel who discuss the issues surrounding managing clinical operations, partnership strategies and compliance & regulation in Asia. In 2014 the 3rd Global Clinical Trials Outsourcing Summit will look at these issues again, particularly in the context of increased regulatory activism by the region's national regulators.
 Topics Clinical, Trials, Development, Outsourcing, Strategy, Asia, Pharmacovigilance, Safety, Regulation, IPR/Publishing Challenges
 Weblink http://www.clinical-trials-events.com/globaloutsourcing.html
 Contact Nick Noakes; Phone: [+44 (0) 1865 849841]; Email: nnoakes@globalengage.co.uk
 Related subject(s) Clinical trials
  
3.2nd AAC — EACR-Sponsored 2nd Anticancer Agents Congress
 Dates 23 Apr 2014 → 25 Apr 2014
[ID=598834] Go to top of page
 LocationBodrum, Turkey
 Abstract Meeting aim to bring all kinds of cancer researchers including those dealing with anti-cancer agents development together and discuss recent achievements in the field of basic cancer research on drug development and their mechanism(s) of action at both molecular and cellular level.
 Topics IN VITRO DRUG SCREENING, ANTICANCER DRUG DISCOVERY/DEVELOPMENT, NOVEL ANTICANCER AGENTS, NOVEL PREDICTIVE / PROGNOSTIC BIOMARKERS, STEM CELL-RELATED PATHWAYS, PROPER EVALUATION OF CYTOTOXICITY RESULTS, CELL DEATH AND CANCER, IN SILICO ANTI-CANCER DRUG DESIGN, TARGETS IN CANCER STEM CELLS
 Weblink http://www.cancerresearch2014.org
 Contact Phone: [+902165410054]; Email: cancerresearch2014@conplus.org
 Related subject(s) Oncology
  
4.Drug Discovery Chemistry 2014
 Dates 23 Apr 2014 → 25 Apr 2014
[ID=583963] Go to top of page
 LocationSan Diego, California, United States
 Abstract Drug Discovery Chemistry is the leading conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to move between concurrent meetings and create a unique program according to personal interests. New this year is Epigenetic Inhibitor Discovery which nicely complements the most popular topics from previous years: Anti-Inflammatories, Protein-Protein Interactions, Macrocyclics and Constrained Peptides, Fragment-Based Drug Discovery, and Kinase Inhibitor Chemistry.
 Topics drug discovery, chemistry, medicinal chemistry, kinase inhibitors, protein-protein interactions, pharmaceuticals, biotechnology, small molecule, anti-inflammatories, epigenetics
 Weblink http://www.drugdiscoverychemistry.com
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
 Related subject(s) Biochemistry and Medicinal Chemistry, Toxicology
  
5.MOKAD congress — 5th Multidisciplinary Cancer Research Congress - V. Multidisipliner Kanser Arastirma Kongresi
 Dates 25 Apr 2014 → 27 Apr 2014
[ID=598866] Go to top of page
 LocationBodrum, Turkey
 Abstract One of the main topics will particularly be the targeting of the cancer stem cells that are considered to be responsible for the resistance to therapy and the recurrence of cancer. World-famous eminent researchers on cancer stem cells from all around the world will be with us.
 Topics - CANCER STEM CELLS AND EPITHELIAL-MESENCHIMAL TRANSITION, NOVEL ANTICANCER SMALL MOLECULES, PLANT-BASED ANTICANCER AGENTS, CYTOTOXICITY METHODS IN ANTICANCER DRUG DEVELOPMENT, CELL DEATH (APOPTOSIS/NECROSIS AND AUTOPHAGY) IN CANCER, MIRNA AND CANCER, JAK
 Weblink http://www.cancerresearch2014.org/
 Contact Phone: [+90 216 541 00 54]; Email: cancerresearch2014@conplus.org
 Related subject(s) Oncology; Molecular Biology
  
6.Biomarkers & Diagnostics World Congress
 Dates 30 Apr 2014 → 02 May 2014
[ID=609064] Go to top of page
 LocationPhiladelphia, PA, United States
 Abstract The World Congress will continue offering a comprehensive coverage of biomarkers in drug development, including translational biomarkers, patient selection and drug-diagnostic co-development. The Executive Summit on Companion Diagnostics is designed to bring together drug development and diagnostics leaders to brainstorm strategies for Rx-Dx co-development, including reimbursement, regulatory, and technology/implementation strategies. A new track on Laboratory-Developed Tests will follow the Clinical Biomarker Assay Development track, for complete coverage on biomarker assay development technologies, regulation, and clinical utility. Finally, a new track on Mutation Analysis for Clinical Biomarkers and Diagnostics will cover the recent research and technologies related to genomic analysis to guide clinical decision making. Please join us for comprehensive scientific coverage and unparallel networking opportunities at the Tenth Anniversary Congress!
 Topics Biomarker, Clinical Biomarkers, translational medicine, personalized medicine, Companion diagnostics, Biomarker assay development and validation, Oncology drug development, safety, patient selection, Biomarker consortia, Protein Biomarkers, Molecular Diagnostics, Partnering Strategies, Drug Safety, Tranlsational Biomarkers, Circulating Tumor Cells, Biomarker Assay Development
 Weblink http://www.biomarkerworldcongress.com/
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
  
7.2-day In-person Seminar on “The A to Z's of Microbial Control, Monitoring and validation of Pharmaceutical Water Systems” in San Diego
 Dates 01 May 2014 → 02 May 2014
[ID=614017] Go to top of page
 LocationSao Paulo, United States
 Abstract This course is designed to provide a microbiology-focused education about all aspects of water systems and how biofilm manages to thrive there. Prior microbiological education or training, though a plus, is not a requirement because engineers and other non-biologists also need this training if they are involved with any aspect of water systems. The instructor will provide the necessary background needed to understand this very important subject matter. This understanding is essential to the proper design, validation, operation, monitoring, maintenance, troubleshooting, and excursion investigations of a high purity water system. Without this understanding, water system control consists of a set of rules that often don't work and can cause very costly system downtime or even product recalls, and leaves the user without a clue as to what went wrong or how to effectively fix it so it doesn't recur.
 Topics Pharmaceutical training, compliance training, FDA training, pharmaceutical water systems, Microbiological Quality, regulatory training, regulatory and compliance
 Weblink http://bit.ly/1a7xdLC
 Contact John Robinson ; Phone: [18004479407]; Email: support@globalcompliancepanel.com
  
8.UMASS Amherst Models to Medicine: Challenges and Opportunities, Kick-Off Symposium
 Start date02 May 2014
[ID=616657] Go to top of page
 LocationAmherst, MA, United States
 Abstract The new Models to Medicine Center of the recently launched Institute for Applied Life Sciences at the University of Massachusetts Amherst is hosting a kick-off symposium on “Models to Medicine: Challenges and Opportunities,” Friday, May 2, 2014. The symposium talks will describe exciting basic biomedical research pursuits that have been translated into therapeutic applications. The day will begin at 11:00 am with a poster session that showcases “Models-to-Medicine” research activities at UMass Amherst, to be held in the new Life Science Laboratories. Box lunches will be available (must be reserved in advance). Next, we will move to the Student Union Ballroom to begin the formal symposium with a panel discussion on the topic of challenges and opportunities arising in translation of basic research outcomes into therapeutic applications, followed by four talks that illustrate this theme. The day will end with a reception to which all attendees are invited. This symposium offers attendees a unique opportunity to hear presentations from leading researchers and to network with academic and industrial researchers from the New England area.
 Topics Therapeutic applications of basic research outcomes.
 Weblink http://www.umass.edu/m2msymposium
 Contact Sarah Loomis; Email: sloomis@umass.edu
 Related subject(s) Molecular Biology; Genomics and Bioinformatics
  
9.CELL CULTURE ENGINEERING XIV
 Dates 04 May 2014 → 09 May 2014
[ID=542635] Go to top of page
 LocationQubec City, Canada
 Abstract Since 1988 the Cell Culture Engineering conferences have been held bi-annually and have developed into the leading global venue for the academic, industrial and regulatory communities for intensive interactions and debates to create solutions for improving human health and life by enabling rapid development and high quality manufacturing of an ever increasing number of viral vaccines, recombinant proteins and monoclonal antibodie. The 2014 conference will be the 14th conference in this highly successful series. This Cell Culture Engineering XIV Conference will bring together 300 selected participats of top academic, industrial and governmental researchers from all over the world. This conference program will focus on topics ranging from the frontiers of fundamental biologic science around animal cells, the engineering challenges of cell culture process development and implementation, the latest regulatory concepts such as QbD and design space for improving process design and product quality, strategies for accelerating development of high quality and cost effective biosimilars and opportunities for international collaborations.
 Weblink http://www.engconfintl.org/14ac.html
 Contact Arlene Conway; Phone: [1-212-514-6760]; Email: arlene@engconfintl.org
  
10.Biologics Formulation and Delivery Summit
 Dates 05 May 2014 → 07 May 2014
[ID=609073] Go to top of page
 LocationBoston, MA, United States
 Abstract Advances in molecular biology and biotechnology have allowed for the large-scale production of effective and potent biotherapeutic drugs. Major research issues in protein/peptide delivery include the stabilization of proteins in delivery devices and the design of appropriate target-specific carriers. CHI's Inaugural Biologics Formulation and Delivery Summit will provide a forum for focused discussions on current challenges and opportunities in delivery of biotherapeutics. This multi-track summit will discuss various formulation and device-based approaches for designing physiologically relevant, patient friendly, targeted biologics products.
 Topics biologics, formulation, drug delivery, formulation development; delivery of biologics, biotherapeutic drugs, biologics delivery
 Weblink http://www.healthtech.com/Biologics-Delivery
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
  
11.PEGS: The Essential Protein Engineering Summit
 Dates 05 May 2014 → 09 May 2014
[ID=609096] Go to top of page
 LocationBoston, MA, United States
 Abstract Over 1,600 participants will gather in Boston’s vibrant seaport district for open forum discussions and collaboration at CHI’s flagship biologics event “PEGS the essential protein engineering summit”. The continued success of PEGS is driven by the growth in biologics worldwide, the quality of scientific programming presented and valuable networking opportunities. 2014 event features Include 1,600+ participants, 20 conferences, 14 short courses, 375+ presentations, 100+ exhibitors, and 175+ posters.
 Topics protein, protein engineering, protein aggregation, protein purification, protein therapeutics, oncology, therapeutic, expression, bioprocessing, antibodies, antibody, antibody-drug conjugates, biologics, phage, yeast, bispecific antibodies, cancer, cancer therapeutics, autoimmune disease, t-cell, peptide, pk/pd, immunogenicity, adc, peptide
 Weblink http://www.pegsummit.com/
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
  
12.Cancer Drug Research & Development Conference — Cancer Drug Research & Development Conference
 Dates 06 May 2014 → 07 May 2014
[ID=589164] Go to top of page
 LocationBerlin, United States
 Abstract We invite you to join us at GTC's Inaugural Cancer Drug Research & Development Conference on May 6-7, 2014 in Berlin, Germany.
 Topics Drug Programs, Cancer Targets, Kinase Inhibitors, Drug Resistance, Metabolic Pathways
 Weblink https://www.gtcbio.com/conference/cancer-drug-research-development-overview
 Contact Phone: [6262566405]; Email: infogtcbio@gtcbio.com
 Related subject(s) Oncology
  
13.Europe Drug Discovery Summit
 Dates 06 May 2014 → 09 May 2014
[ID=589957] Go to top of page
 LocationBerlin, Germany
 Weblink http://www.gtcbio.com/conference/edds-overview
 Contact Kristen Starkey; Phone: [6262566405]; Email: infogtcbio@gtcbio.com
  
14.Protein Kinases in Drug Discovery - Europe
 Dates 08 May 2014 → 09 May 2014
[ID=576220] Go to top of page
 LocationBerlin, Germany
 Abstract This premier conference will host an exciting group of professionals from the academic, biotech, pharmaceutical, and business communities, and will focus on drug discovery aspects within the protein kinases field. A balance of both academic and industry experts will facilitate discussion.
 Weblink http://www.gtcbio.com/conference/protein-kinases-drug-discovery-europe-overview
 Contact Phone: [16262566405]; Email: infogtcbio@gtcbio.com
 Related subject(s) Biology; Biochemistry and Medicinal Chemistry, Toxicology
  
15.Drug Design Europe — Drug Design & Medicinal Chemistry Conference
 Dates 08 May 2014 → 09 May 2014
[ID=581353] Go to top of page
 LocationBerlin, Germany
 Abstract The meeting will provide a forum for scientists across multiple disciplines, from both industry and academia, to connect and share complementary perspectives. We will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more. In addition to scientific presentations, we will have dedicated times for networking among delegates.
 Weblink http://www.gtcbio.com/conference/medchem-overview
 Contact Phone: [(626) 256-6405]; Email: infogtcbio@gtcbio.com
 Related subject(s) Biochemistry and Medicinal Chemistry, Toxicology; Biotechnology
  
16.HIV Drug Therapy in the Americas
 Dates 08 May 2014 → 10 May 2014
[ID=565185] Go to top of page
 LocationSao Paulo, Brazil
 Abstract This 3-day scientific meeting evolved from the scientifically strong, Glasgow UK HIV Drug Therapy meeting. HIV in the Americas has established itself as an accessible, regionally relevant programme focusing on a range of issues relating to HIV treatment. A truly global faculty join together with key regional leaders to discuss, within plenary and case-based presentations, topics of real interest to those working within HIV in the ‘Americas’ region. Abstract presentations will encourage audience participation and discussion.
 Weblink http://www.hivamericas.org
 Contact Phone: [01625644127]; Email: hivamericas@kp360group.com
  
17.Towards New Therapeutics for Diseases of the Developing World
 Dates 11 May 2014 → 13 May 2014
[ID=609448] Go to top of page
 LocationMadrid, Spain
 Abstract Designing drugs to fight diseases that cause high mortality and morbidity amongst the people of the developing world is a global challenge. This meeting will focus on medicinal chemistry approaches to making new medicines, with keynote talks from international experts, accompanied by a series of perspectives detailing case histories in drug discovery. The exciting spread of themes should attract delegates from both industry and academia, highlighting the latest developments in tackling malaria, TB and kinetoplastid diseases.
 Topics Designing drugs to fight diseases that cause high mortality and morbidity amongst the people of the developing world is a global challenge. This meeting will focus on medicinal chemistry approaches to making new medicines, with keynote talks from international experts, accompanied by a series of perspectives detailing case histories in drug discovery. The exciting spread of themes should attract delegates from both industry and academia, highlighting the latest developments in tackling malaria, TB and kinetoplastid diseases.
 Weblink https://www.soci.org/Events/Display-Event.aspx?EventCode=FCHEM138
 Contact Patricia Cornell ; Phone: [+44 (0)20 7598 1561]; Email: conferences@soci.org
  
18.Advances in Cancer Screening and Prevention Research
 Start date12 May 2014
[ID=571548] Go to top of page
 LocationLondon, United Kingdom
 Abstract This event will discuss current research and clinical trials for the prevention of cancer, focussing on screening, early detection and chemoprevention. The meetings will be run in an informal setting with plenty of opportunity for networking and debate.
 Weblink http://www.regonline.co.uk/cancerscreen2014
 Related subject(s) Oncology; Clinical trials
  
19.EU REGULATIONS on VARIATIONS
 Start date12 May 2014
[ID=612027] Go to top of page
 LocationISTANBUL, Turkey
 Abstract This course is unique in its design as it explains the properties, processes and test procedures involved in simple terms and relates them directly to the different requirements in the variations.
 Topics variations, regulation, registration, regulatory affairs, pharmaceutical, pharmaceutic, drug
 Weblink http://www.mkistanbul.com/events.html
 Contact Oya Guven , Event Manager; Email: og@mkistanbul.com
  
20.Training — The Pharma Brand Planning Course - with Edouard Demeire
 Dates 12 May 2014 → 13 May 2014
[ID=574671] Go to top of page
 LocationBrussels, Belgium
 Abstract This course is a must-have if you want to learn how to precisely determine the pharma marketing tactics that will effectively leverage opportunities in the market. All too often, pharma brand plans seem to be replicas of last year’s planning templates, and the link between upfront analyses and final tactical action plans is often not clear either. In this course, pharma marketing expert Edouard Demeire will force you to think out-of-the-box. He will learn you how to use powerful analytical and decision support tools in a brand planning process that culminates in the design of a competitive marketing mix. You will learn about both “Red Ocean” marketing strategies and “Blue Ocean” marketing strategies in pharmaceutical markets.
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-brand-planning-course.html
 Contact Annelies Swaan, Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
21.Prenatal Molecular Diagnostics Europe
 Dates 12 May 2014 → 13 May 2014
[ID=609127] Go to top of page
 LocationLisbon, Portugal
 Abstract This conference aims to take an in-depth look at the current trends and guidelines in Europe for prenatal molecular diagnostics, while providing perspectives on how this rapidly changing field is likely to develop in Europe over the next several years. In addition to the technical issues, there are a number of other factors, including geographic differences, coverage of diagnostic tests from one country to another, challenges of clinical implementation of new procedures and the increased need for genetic counseling perspectives, that need to be understood in order to forecast how this field is likely to develop in Europe.
 Topics prenatal, molecular diagnostics, fetal cell, cell free DNA, karotyping, cytogenetic, DNA diagnostics, next-generation sequencing, NGS, biomarkers, pregnancy, genetic counseling, prenatal diagnosis
 Weblink http://www.healthtech.com/prenatal-diagnostics-europe
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
 Related subject(s) Obstetrics/Gynecology
  
22.Course — Practical Approaches to Quality by Design (QbD) for Pharmaceutical Process Research, Development and Manufacturing
 Dates 13 May 2014 → 15 May 2014
[ID=568569] Go to top of page
 LocationBarcelona, Spain
 Weblink http://www.scientificupdate.co.uk/training/scheduled-courses/details/215-Practical Approaches to Quality by Design for Pharmaceutical Process R.html?D_and_Manufacturing=
  
23.Anti-Cancer Therapeutics: From research to trials to treatment
 Start date14 May 2014
[ID=559078] Go to top of page
 LocationLondon, United Kingdom
 Abstract This event will discuss development of therapies for cancer treatment including, but not exclusively biologicals, looking at discoveries in the laboratory to clinical phase trials. This is not only an ideal place to showcase research and development but also to discover what may become new on the market and to network with experts in the field
 Weblink http://www.regonline.co.uk/anticancer2014
 Related subject(s) Oncology
  
24.IMPURITIES in PHARMACEUTICALS
 Dates 14 May 2014 → 15 May 2014
[ID=611951] Go to top of page
 LocationISTANBUL, Turkey
 Abstract This 2-days seminar will help define the different sorts of impurities that may occur in drug substances and finished dosage forms. It will help in differentiating between degradation products and other impurities and will look at the requirements for determining degradants through the use of validated analytical methods incorporated into regulated stability testing programs in accordance with ICH/EMA and revised FDA requirements.
 Topics impurity, impurities, pharma, pharmaceutic, pharmaceuticals, registration, regulatory, regulatory affairs, analytical, analytical chemistry, stability, validation, quality, quality control, quality assurance
 Weblink http://www.mkistanbul.com/events.html
 Contact Oya Guven , Event Manager; Email: og@mkistanbul.com
 Related subject(s) Professional Training Events in Chemistry; Industrial Chemistry and Green Chemistry
  
25.IL-6 Midyear Meeting 2014, Kiel — Interleukin 6: Biology-Pathophysiology-Therapy, ICIS Midyear Conference 2014
 Dates 14 May 2014 → 17 May 2014
[ID=566604] Go to top of page
 LocationKiel, Germany
 Abstract The Midyear ICIS-Meeting 2014 is dedicated to the cytokine Interleukin-6. Interleukin-6 is a classical inflammatory cytokine, which is the major inducer of the hepatic acute phase response. A pivotal role of Interleukin-6 in the development of T-cell populations important for inflammatory processes has been defined during the last years. The blockade of Interleukin-6 activity by the monoclonal antibody Tocilizumab for the treatment of Rheumatoid Arthritis and systemic juvenile idiopathic arthritis has been approved in more than 100 countries. Other ways of blocking Interleukin-6 activity are under preclinical and clinical development. It has been many years since the last monothematic conference on Interleukin-6 and related cytokines. The main objective of the Meeting in Kiel is to bring together the outstanding experts in Interleukin-6 biology and pathophysiology. Moreover, the state of the art on Interleukin-6 and interleukin-6 receptor as therapeutic targets will be discussed and clinical experience will be presented. The participants will be invited to present data and interact with the experts in the Interleukin-6 field.
 Topics Interleukin 6, IL-6, IL-6-Receptor, Pathophysiology, Cytokine, cytokine network, Inflammation, Rheumatoid Arthritis, Tocolizumab, gp130, therapeutic targets, ICIS
 Weblink http://www.Kielcytokines2014.com
 Contact Sherwood Reichard ; Phone: [+706 228-4655]; Email: info@kielcytokines2014.com
 Related subject(s) Medicine (in general); Oncology
  
26.Training — The Pharma Forecasting Course - with Gary Johnson
 Dates 19 May 2014 → 20 May 2014
[ID=574692] Go to top of page
 LocationBrussels, Belgium
 Abstract By attending, you will learn how to produce reliable sales forecasts and to critically asses the forecasts produced by others. To that purpose you will learn to distinguish between factors that have an impact on the forecasts of pharmaceuticals versus those that don’t (evidence-based), as well as the underlying concepts that explain why. What’s more, you will leave with an Excel-based forecasting tool developed by Gary Johnson so that you can put the learning into practice as of day one.
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-forecasting-course.html
 Contact Annelies Swaan, Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
27.Training — Principles of Pharma Market Access in Europe - with Lloyd Morgan and Mark Silvey
 Dates 20 May 2014 → 21 May 2014
[ID=574500] Go to top of page
 LocationZurich (Opfikon-Glattbrugg), Switzerland
 Abstract This course is a great learning experience for anyone willing to know what market access really means, who the key stakeholders are in Europe, what the system dynamics are in key markets which determine market access, how to communicate with and influence the different stakeholders, and how to organize resources internally.
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-market-access-course.html
 Contact Annelies Swaan, Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
28.5th Annual Biosimilars Asia 2014
 Dates 20 May 2014 → 23 May 2014
[ID=614220] Go to top of page
 LocationShanghai, China
 Abstract IBC’s Biosimilars Asia 2014, the largest and most cutting-edge conference will this year focus on partnerships and emerging models of collaboration that provide win-win solutions for regional biosimilar companies and MNCs.
 Topics biosimilars, biobetters, generics, biologics, biotechnology, china pharmaceuticals, drug delivery, DDT china, China R&D
 Weblink http://www.biosimilarsasia.com/
 Contact Rita Parasurum; Phone: [6565082401]; Email: rita.parasurum@ibcasia.com.sg
  
29.11th Annual Mastering Medicinal Chemistry
 Dates 21 May 2014 → 22 May 2014
[ID=609103] Go to top of page
 LocationBoston, MA, United States
 Abstract Senior executives and industry thought leaders from Pfizer, Roche, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, AstraZeneca and many more will participate in this year’s program with inspiring discussions on the future role of medicinal chemistry and its contribution to improved drug discovery rates. Senior level chemists from leading life science companies will also discuss how kinetics and residence time, targeted tissue delivery, and allosteric inhibitors enhance profiles or modulate difficult targets. Network and share case studies on difficult targets with industry leading chemists and senior thought leaders during panel discussions, guided roundtable discussions and dedicated exhibit hall hours.
 Topics medicinal chemistry, chemistry, drug discovery, kinetics, tissue delivery, allosteric inhibitors, small molecules, pharma, macrocycles, kinase inhibitors, drug design, ADCs, antibody-drug conjugates, allosteric modulator
 Weblink http://www.healthtech.com/Medicinal-Chemistry
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
  
30.Structure-Based Drug Design
 Dates 21 May 2014 → 22 May 2014
[ID=609102] Go to top of page
 LocationBoston, MA, United States
 Abstract Experimental methods such as X-ray crystallography, NMR, and computational chemistry techniques have led to a better understanding and larger knowledge base of 3-dimensional structures and binding events, encouraging rapid development of structure-based drug design. Cambridge Healthtech Institute’s Fourteenth Annual Structure-Based Drug Design event will showcase informative, high-quality case studies, innovative techniques, and strategies to move from computation to experiment, and finally, to drug. Top scientists from pharma and biotech will address how they are hitting epigenetic targets, provide updates on the newest wave of GPCRs and other membrane proteins, and discuss the latest in fragment-based drug design. Attendees will return to their organizations with fresh perspectives and new ideas to maximize productivity and increase successes in drug discovery.
 Topics drug design, structure-based drug design, structure-based design, computational methods, computational chemistry, ISCB, medicinal chemistry, computational technology for drug discovery, structural geonomics, molecular dynamics simulation, fragment-based drug discovery, structure-based approaches, virtual screening, fragment-based design
 Weblink http://www.healthtech.com/structure-based-drug-design
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
  
31.World Pharma Congress
 Dates 21 May 2014 → 23 May 2014
[ID=609093] Go to top of page
 LocationBoston, MA, United States
 Abstract After spending 12 years in Philadelphia the World Pharma Congress is moving to Boston, which is buzzing with new findings and technologies that can potentially revolutionize the way in which traditional preclinical drug discovery is done. World Pharma Congress 2014 will provide a forum for scientists and clinicians to meet to exchange ideas and launch collaborations - here are some reasons why you don't want to miss joining us in the Pharma Hub of Boston!
 Topics pharma, cardiotoxicity, pain, targeting pain, preclinical models, oncology, molecular imaging, imaging, drug safety, neurotoxicity, cardiotoxicity, hepatotoxicity, animal models of pain, biologics, animal model, drug discovery, Parkinson's Disease, ADME, cancer, formulation, drug delivery
 Weblink http://www.worldpharmacongress.com/
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
  
32.2-day In-person Seminar on “Validation and 21 CFR Part 11 Compliance of Computer Systems”
 Dates 22 May 2014 → 23 May 2014
[ID=621796] Go to top of page
 LocationZurich, Switzerland
 Abstract Computer Systems Validation (CSV) also known as Software Validation is all-pervasive in the Life Sciences Industry . It is a requirement of all the predicate rules, as well as 21 CFR 11 and Annex 11. However, unless one knows how to implement CSV, it is often very hard to detect the requirement for CSV, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the FDA has stepped up 21 CFR 11 inspections that include CSV.
 Topics 21 CFR Part 11 Compliance, Computer Systems Validation, CSV Compliance, Regulatory Compliance, 21 CFR Part 11
 Weblink http://bit.ly/1dSA8R7
 Contact Event Coordinator ; Phone: [8004479407]; Email: support@globalcompliancepanel.com
 Related subject(s) Clinical Data Management
  
33.3rd Annual ORPHAN DRUGS FORUM
 Dates 22 May 2014 → 23 May 2014
[ID=621751] Go to top of page
 LocationBarcelona, Spain
 Abstract There is an undoubted need to innovate when it comes to the area of rare diseases. Orphan drugs necessitate a different approach ranging from clinical trials to working with patients and regulatory bodies.
 Topics Orphan Drugs Pharmaceuticals Pricing & Reimbursement Alternative Ways to Raise Funds Optimizing Orphan Drugs Development
 Weblink http://pharma.flemingeurope.com/orphan-drug-congress?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=BALS141_home
 Contact Andrea Weber; Phone: [+421 257 272 162]; Email: andrea.weber@pharmafe.com
  
34.GPCR — GPCR Structure, Function and Drug Discovery Conference
 Dates 22 May 2014 → 23 May 2014
[ID=607181] Go to top of page
 LocationCambridge, MA, United States
 Abstract The GPCR conference seeks to provide a forum for researchers from both industry and academia to exchange complimentary perspectives on the latest discovery. We will cover topics such as biased signaling, novel ligands, X-ray crystallography, and many more. Join us to discuss the future of drug discovery and the role of GPCRs!
 Topics biased signaling, novel ligands, X-ray crystallography
 Weblink http://www.gtcbio.com/conference/gpcr-overview?utm_source=gpcrposting&utm_medium=website&utm_campaign=gpcr2014
 Contact Kristen Starkey ; Phone: [((626-256-6405))]; Email: kristen.starkey@gtcbio.com
  
35.Property-Based Drug Design
 Dates 22 May 2014 → 23 May 2014
[ID=609112] Go to top of page
 LocationBoston, MA, United States
 Abstract One of the most challenging aspects of drug discovery remaining is the identification of new molecular entities (NMEs) with the desirable physicochemical properties and absorption, distribution, metabolism, and excretion (ADME) profiles that can be formulated into safe and efficacious drug products. The third annual Property-Based Drug Design conference will bring together leading experts from industry and academia to discuss advanced tools and technologies being used for better understanding of physicochemical and bio-physical properties and how the new understanding is applied to the drug discovery processes and pharmaceutical development.
 Topics drug design, pharma, pharmaceutical, drug discovery, new molecular entity, NME, physicochemical, drug formulation, high-throughput screening
 Weblink http://www.healthtech.com/Property-Based-Drug-Design
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
  
36.Chemical Biology for Target Validation
 Dates 22 May 2014 → 23 May 2014
[ID=609111] Go to top of page
 LocationBoston, MA, United States
 Abstract Small molecule drug discovery has approached a critical junction where the rigorous pre-clinical validation and prioritizing of novel targets is of utmost importance. Challenged with thinning development pipelines and significant losses in revenue, greater emphasis is being placed on the stringent selection and validation of targets and candidate molecules to increase success and reduce attrition rates in phase II trials. In response to this challenge, a synergy between drug discovery and chemical biology is emerging as a vital component to providing adequate confidence before launching full discovery programs. The development and utilization of high-quality chemical probes in combination with disease-relevant phenotypic systems provides a powerful approach to obtain a deeper interrogation of target-phenotype relationships - ultimately enriching target validation.
 Topics chemical biology, target validation, medicinal chemistry, small molecule, drug discovery, target-phenotype relationship, structural biology, chemical proteomics, synthetic chemistry, chemistry, proteomics
 Weblink http://www.healthtech.com/Target-Validation
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
 Related subject(s) Biochemistry and Medicinal Chemistry, Toxicology
  
37.Drug Discovery Summit
 Dates 22 May 2014 → 23 May 2014
[ID=611957] Go to top of page
 LocationCambridge, United States
 Abstract We invite you to attend the Drug Discovery Summit, which will take place May 22- 23, 2014 in Cambridge, MA.
 Topics drug, discovery, summit
 Weblink http://www.gtcbio.com/component/conference/?file=home&cn=Drug+Discovery+Summit&cid=87&utm_source=drugdiscovery%2B&utm_medium=EventListing&utm_content=drugdiscovery%2B&utm_campaign=drugdiscovery%2B
 Contact Kristen Starkey ; Phone: [626-256-6405]; Email: infogtcbio@gtcbio.com
  
38.DDI Workshop Marbach Castle — DDI 2014 – 5th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions
 Dates 25 May 2014 → 27 May 2014
[ID=612732] Go to top of page
 LocationÖhningen, Germany
 Abstract This year the 5th International Drug-Drug Interaction Workshop at Marbach Castle will take place from May 25th to 27th 2014. As in the previous years, the topics of the 5th International DDI Workshop will be covered by distinguished international scientists and experts from academia, pharmaceutical companies, contract research organizations, consultancies as well as government and regulatory agencies. The 16 speakers of this year will come from 5 different countries (Germany, Great Britain, Japan, USA and Switzerland), thereof 4 from the US. They will present scientific news, the content of Japanese PMDA- and US-FDA draft guidelines and state of the art lectures. The scientific sessions will cover regulatory aspects of drug-drug interactions (FDA draft guideline, PMDA draft guideline), herb-drug and food-drug interactions and drug-drug interactions involving drug transporters. It’s the first time that herb-drug and food-drug interactions will be addressed in detail.
 Topics drug-drug interaction, ddi workshop, Marbach Castle, food-drug interaction, herb-drug interaction, transporter proteins
 Weblink http://www.cr-appliance.com
 Contact Karen Grave-Hermann ; Phone: [49(0)6051-97 166 91]; Email: karen.grave-hermann@cr-appliance.com
  
39.PHARMACEUTICAL MICROBIOLOGY
 Start date27 May 2014
[ID=611974] Go to top of page
 LocationISTANBUL, Turkey
 Abstract The course will instruct delegates in basic microbiology, including: Microbial families and the Microbial World. What impact they have on production and products. Discuss the role of the microbiology lab, appropriate tests and requirements. Review personnel and facility hygiene. Review of regulatory expectations of the microbiological control of production processes and facilities. We will also discuss microbiological control of water systems used in the Pharmaceutical Industry, including endotoxins.
 Topics microbiology, biology, pharmaceutical, pharmaceutic, production, quality, quality control, quality assurance, engineering, regulatory, microbiology lab, microbial, microbial families, hygiene
 Weblink http://www.mkistanbul.com/events.html
 Contact Oya Guven , Event Manager; Email: og@mkistanbul.com
  
40.2-day In-person Seminar on “Validation and 21 CFR Part 11 Compliance of Computer Systems”
 Dates 29 May 2014 → 30 May 2014
[ID=621848] Go to top of page
 LocationSydney, Australia
 Abstract Computer Systems Validation (CSV) also known as Software Validation is all-pervasive in the Life Sciences Industry . It is a requirement of all the predicate rules, as well as 21 CFR 11 and Annex 11. However, unless one knows how to implement CSV, it is often very hard to detect the requirement for CSV, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the FDA has stepped up 21 CFR 11 inspections that include CSV.
 Topics 21 CFR Part 11 Compliance, Computer Systems Validation, CSV Compliance, Regulatory Compliance, 21 CFR Part 11
 Weblink http://bit.ly/1ikJfqs
 Contact Event Coordinator ; Phone: [8004479407]; Email: support@globalcompliancepanel.com
 Related subject(s) Clinical Data Management
  
41.Structural Basis of Pharmacology — Deeper Understanding of Drug Discovery through Crystallography
 Dates 30 May 2014 → 28 May 2014
[ID=581086] Go to top of page
 LocationErice, Italy
 Weblink http://www.crystalerice.org/Erice2014/2014.htm
 Related subject(s) Applied Physics: X-rays, Synchrotron Radiation and Crystallography
  
42.Transfer of Analytical Methods for Pharmaceutical Analysis
 Start date30 May 2014
[ID=619573] Go to top of page
 LocationLondon, United Kingdom
 Abstract Transferring an analytical method from one laboratory to another should be straightforward but unfortunately it is a process which is often problematic. Recognition of this has resulted in a new USP chapter <1224> and an update to chapter 6 of the EU GMP regulations. In this one day course the different approaches to transfer are explored fully and case studies are used extensively to follow the process from review of the method prior to transfer, to creating a suitable protocol with relevant acceptance criteria, and evaluating the results generated to assess whether the transfer has been successful.
 Topics Method transfer, Analytical, Pharmaceutical method transfer.
 Weblink http://www.mournetrainingservices.co.uk/course_list.html
 Contact Oona McPolin; Phone: [+44 (0) 28 417 73724]; Email: info@mournetrainingservices.co.uk
  
43.Drug Safety — Bridging the Divide Between Pre-clinical and Clinical Drug Safety
 Dates 01 Jun 2014 → 06 Jun 2014
[ID=586744] Go to top of page
 LocationStonehill College, Easton, MA, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Clinical trials
  
44.15th Annual Drug Discovery Summit 2014
 Dates 02 Jun 2014 → 03 Jun 2014
[ID=609000] Go to top of page
 LocationGeneva, Switzerland
 Abstract Europe’s leading summit for executives working in discovery chemistry, discovery technology, research strategy and drug design.
 Topics Drug Discovery, Drug Design, Discovery Chemistry, Discovery Technology, Research Strategy, Medicinal Chemistry, GPCR, Allosteric, Protein-Protein Interaction, Compound Profiling, Drug Target, Fragment based Drug, Structure based Drug, Flow Chemistry, Synthetic Chemistry, Ion Channel, Phenotypic Screening, Target Screening, Drug Screening.
 Weblink http://www.drugdiscovery-summit1.com/
 Contact Danielle Dalby , Marketing Manager; Phone: [+44 01865 248 455]; Email: d.dalby@oxfordglobal.co.uk
  
45.2nd Annual Discovery Chemistry & Drug Design Congress 2014
 Dates 02 Jun 2014 → 03 Jun 2014
[ID=609043] Go to top of page
 LocationGeneva, Switzerland
 Abstract The congress is part of the 15th Annual Drug Discovery Summit – Europe’s premier networking and discussion forum for pharmaceutical leaders. The congress is also co-located with the 6th Annual Drug Development Congress, a two day event focused on predictive science and translational medicine.
 Topics Discovery Chemistry, Drug Design
 Weblink http://www.discoverychemistry-congress1.com/
 Contact Danielle Dalby , Marketing Manager; Phone: [+44 1865 248 455]; Email: d.dalby@oxfordglobal.co.uk
  
46.NBE — Nanobio-Europe 2014 - Nano Medicine: Nanomaterials in Diagnostics and Therapy
 Dates 02 Jun 2014 → 04 Jun 2014
[ID=610932] Go to top of page
 LocationMuenster, Germany
 Abstract Nanobiotechnology, as one of today’s most fascinating and challenging fields of research, is a multi-disciplinary and fast developing research area with revolutionary innovations in almost any field of science and engineering. The nanobio-europe conference is going to present the most recent international developments in the field of nanobiotechnology and is providing a platform for interdisciplinary communication, new cooperations and projects to the participants from science and industry.
 Topics Nano for Diagnostics, Imaging and Sensing, NanoAnalytics, Nano Toxicology, Functionalized Materials for Bio/Medicine, Nano for Drug and Theranostics, Regenerative Medicine/Implants, EU Horizon 2020
 Weblink http://www.nanobio-europe.com/
 Contact CeNTech GmbH ; Phone: [+49 251 53406 100]; Email: info@nanobio-europe.com
 Related subject(s) Biotechnology; Nanoscale Particles, Colloids and Emulsions
  
47.CC — MENA Pharmaceutical Cold Chain 2014
 Dates 03 Jun 2014 → 04 Jun 2014
[ID=621126] Go to top of page
 LocationDubai, United Arab Emirates
 Abstract The conference will engage local and regional stakeholders and highlight region’s cold chain practices to overcome challenges
 Weblink http://www.menacoldchain.com
 Contact Phone: [97143116300]; Email: maha.siddiqui@mci-group.com
  
48.Training — The e-Medical Affairs Course - with Fonny Schenck
 Dates 03 Jun 2014 → 04 Jun 2014
[ID=574778] Go to top of page
 LocationLondon, United Kingdom
 Abstract Learn in 2-days from expert Fonny Schenck how to leverage the power of the internet in Medical Affairs - How to design a digital strategy across key disciplines (medical education, KOL mgt ...) - How to integrate digital in a balanced Medical Mix while respecting legal and regulatory guidelines.
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-e-medical-affairs-course.html
 Contact Annelies Swaan, Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
49.Training — Late Stage Pharma Lifecycle Management - with Dr. Neal Hansen
 Dates 05 Jun 2014 → 06 Jun 2014
[ID=574492] Go to top of page
 LocationLondon, United Kingdom
 Abstract This course will provide managers with the understanding and decision making insight to develop late stage LCM plans that enhance lifecycle value, building from thought-provoking presentations, real world case studies and interactive exercises.
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-lifecycle-management-course.html
 Contact Annelies Swaan, Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
50.ECI — VACCINE TECHNOLOGY V
 Dates 08 Jun 2014 → 13 Jun 2014
[ID=614777] Go to top of page
 LocationPlaya del Carmen, Mexico
 Abstract This conference will give us the opportunity to build on the strong momentum established at Vaccine Technology IV. Our goal is to gather together many of the key leaders in the field to discuss and review progress made in generating new vaccine targets, new technologies for vaccines and new adjuvants. We will also discuss key strategic issues such as how to generate a new vaccine very quickly and also how to make vaccines more available to the developing world.
 Topics New basic research , vaccine development, new immunology , discoveries , vaccine technology, new clinical assays/correlates(nanoparticles)
 Weblink http://www.engconf.org/conferences/biotechnology/vaccine-technology-v-2/
 Contact ARLENE CONWAY; Phone: [(1-212-515-6760)]; Email: info@engconfintl.org
  
51.World Vaccine Congress Asia 2014
 Dates 09 Jun 2014 → 12 Jun 2014
[ID=617413] Go to top of page
 LocationSingapore, Singapore
 Abstract The 8th annual World Vaccine Congress Asia is the region’s largest event dedicated to vaccine business development, science and technology development: a strategic keynote conference and a series of seminars.
 Topics Vaccine, Asia, Partnerships, seminars, vaccine development
 Weblink http://www.terrapinn.com/2014/world-vaccine-congress-asia/#world-vaccine-congress-asia
 Contact Rebecca Koh , Terrapinn Pte Ltd; Phone: [+65 6322 2725]; Email: rebecca.koh@terrapinn.com
  
52.World Orphan Drugs Congress Asia
 Dates 10 Jun 2014 → 11 Jun 2014
[ID=617414] Go to top of page
 LocationSingapore, Singapore
 Abstract The World Orphan Drug Congress Asia 2014 is Asia's largest orphan drug industry event. This event is committed to fostering partnerships and relationships between industry, governments, payers, investors and patients.
 Topics Orphan Drugs, Congress, Asia, Partnerships, drug development
 Weblink http://www.terrapinn.com/conference/world-orphan-drugs-congress-asia/
 Contact Rebecca Koh , Terrapinn Pte Ltd; Phone: [+65 6322 2725]; Email: rebecca.koh@terrapinn.com
  
53.Efficient Methods for Hit ID
 Start date11 Jun 2014
[ID=621792] Go to top of page
 LocationLondon, United Kingdom
 Abstract Much research into new medicines is now taking place in smaller companies or in departments with limited budgets for expensive and slow High Throughput Screens. Furthermore, screening capacity for certain target classes can be limited by automated screening technology capabilities. Hit discovery therefore has to use smarter, cheaper and more effective strategies; even large companies need to contain costs and make use of faster hit discovery processes. This meeting will examine opportunities for conducting hit discovery more efficiently, from the creation of lead-like collections, knowledge based design of specific protein ligands, to exploiting informatics in directing compound synthesis choices. It will demonstrate future strategies being adopted by both small and large organisations, new initiatives such as the European Lead Factory, as well as considering novel approaches.
 Weblink https://www.soci.org/General-Pages/Display-Event.aspx?EventCode=FCHEM416
 Contact SCI Conferences ; Phone: [(442075981561)]; Email: conferences@soci.org
  
54.Biosimilars — Commercial and IP Considerations
 Start date11 Jun 2014
[ID=611986] Go to top of page
 LocationISTANBUL, Turkey
 Abstract This 1-day seminar on Biosimilars will look at all aspects of biosimilars in both highly regulated and less regulated markets, including the EU regulatory landscape and how it has helped the biosimilar market to develop a long way ahead of the US. The seminar looks as factors such as the challenges of product development, the problems of commercialisation and who are the key players who have found the answers. By attending delegates will gain a comprehensive outlook on all the major issues surrounding biosimilars.
 Topics biosimilars, biologicals, biogenerics, pharma, pharmaceutical, biotechnology, regulatory, product development, registration, big pharma, generic, original
 Weblink http://www.mkistanbul.com/events.html
 Contact Oya Guven , Event Manager; Email: og@mkistanbul.com
  
55.DDTWC — Drug Discovery & Therapy World Congress 2014
 Start date16 Jun 2014
[ID=604935] Go to top of page
 LocationBoston, United States
 Abstract This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences has been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.
 Weblink http://www.ddtwc.com/
 Contact One Boston Place; Phone: [((+1-857-2398855))]; Email: faizan@ddtwc.com
  
56.IWPCPS-16 — International Workshop on Physical Characterization of Pharmaceutical Solids
 Dates 16 Jun 2014 → 19 Jun 2014
[ID=575927] Go to top of page
 LocationPrague, Czech Republic
 Organizer assa Inc.
 Weblink http://www.assainternational.com/workshops/iwpcps-16/
 Related subject(s) Solid-state Chemistry
  
57.ddtwc — Drug Discovery and Therapy World Congress 2014
 Dates 16 Jun 2014 → 19 Jun 2014
[ID=570329] Go to top of page
 LocationBoston, United States
 Abstract This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences has been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.
 Weblink http://www.ddtwc.com/
 Contact Ms. Hasina Habib , Eureka Conference, inc ; Phone: [+1-857-2398855]; Email: info@ddtwc.com
  
58.Therapeutic proteins and antibodies: from design to function
 Start date18 Jun 2014
[ID=571525] Go to top of page
 LocationLondon, United Kingdom
 Abstract This meeting discusses new developments in therapeutic protein and antibody engineering with specific focus on science and technology of modifying proteins and antibodies (and the conditions of their manufacture) toward specific predefined properties that allow them to act as effective biological drugs. Special emphasis will be placed on structure-function relationships, mechanisms of action, potency and efficacy in disease-relevant models and in clinical trials. There will be plenty of opportunity for discussion and debate addressing the wide range of disciplines applied to the rapid and economical production of these molecules for biological therapies
 Weblink http://www.regonline.co.uk/thera2014
 Related subject(s) Medicine (in general)
  
59.ISOPT Clinical 2014 — The 11th International Symposium on Ocular Pharmacology and Therapeutics
 Dates 19 Jun 2014 → 22 Jun 2014
[ID=561445] Go to top of page
 LocationReykjavik, Iceland
 Abstract We invite you to join us in Iceland and use this unique opportunity to present your original research and exchange your experiences in retinal diseases, inflammation, cornea and external diseases, glaucoma or basic science topics by submitting an abstract.
 Topics Retinal Diseases, Glaucoma, External Eye Diseases, Inflammation & Infection, Basic Science, Drug Development
 Weblink http://www.isopt.net
 Contact Gail Tito; Phone: [41 22 5330 948]; Email: isopt@isopt.net
 Related subject(s) Ophthalmology
  
60.Alzheimer's Disease: Biomarker Discovery and Assay Development
 Start date23 Jun 2014
[ID=571491] Go to top of page
 LocationLondon, United Kingdom
 Abstract Currently, there are many biomarkers for diagnosis of Alzheimer's disease. However most of them do not provide consistent results. This event will discuss current research aimed at obtaining reliable biomarkers which could be used to diagnose Alzheimer's disease at very early stage and also to provide objective and reliable measures of disease progress.
 Weblink http://www.regonline.co.uk/AlzBiomark2014
 Related subject(s) Neurology
  
61.TNPR 2014 — Trends in Natural Products Research 2014
 Dates 23 Jun 2014 → 25 Jun 2014
[ID=576376] Go to top of page
 LocationOlomouc, Czech Republic
 Abstract The Phytochemical Society of Europe (PSE) cordially invites you to a young scientists meeting devoted to “Trends in Natural Products Research” which will take place in Olomouc, Czech republic.
 Topics natural products chemistry, cultivation and breeding of plants, biotechnology, molecular pharmacology, drug discovery and development, analytical chemistry, separation
 Weblink http://www.tnpr2014.com/
 Contact Miroslav Strnad; Phone: [+420585634580]; Email: info@tnpr2014.com
 Related subject(s) Food Chemistry, Agronomy and Food Production
  
62.Alzheimer's Disease: Vaccine Development
 Start date24 Jun 2014
[ID=571567] Go to top of page
 LocationLondon, United Kingdom
 Abstract Multiple potential treatments for Alzheimer's disease are currently under investigation, including several compounds being studied in phase 3 clinical trials. This event will discuss current basic research to develop vaccine through to clinical trial results. There will be plenty of opportunity for discussion and debate.
 Weblink http://www.regonline.co.uk/AlzVac2014
 Related subject(s) Neurology; Clinical trials
  
63.Training — The Pharmaceutical Out-licensing Course - with David Scott
 Dates 24 Jun 2014 → 25 Jun 2014
[ID=574639] Go to top of page
 LocationZurich (Opfikon-Glattbrugg), Switzerland
 Abstract The Pharmaceutical Out-licensing Course is a powerful hands-on course for anyone responsible for out-licensing pharmaceuticals, but other executives involved in the licensing and due diligence process too, as well as new business development executives, will greatly benefit from this course.
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-out-licensing-course.html
 Contact Annelies Swaan, Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
64.Demyelination and Remyelination: From Mechanism to Therapy
 Start date26 Jun 2014
[ID=617713] Go to top of page
 LocationNew York City, United States
 Abstract This translational conference will highlight biological and clinical findings in myelin development, new techniques for brain imaging and for screening molecular targets, and novel therapeutics that promote remyelination.
 Topics neuroimaging, MS, multiple sclerosis, white matter, neurodegeneration, neurodegenerative disease, myelin, demyelination, remyelination, myelination, stem cell, induced pluripotent stem cell, induced pluripotent stem cells, axon, MRI, PET, neuroinflammation, neuroinflammatory, oligodendrocyte, oligodendrocyte precursor, remyelinate
 Weblink http://www.nyas.org/myelin2014
 Contact Phone: [1-212-298-8640]; Email: customerservice@nyas.org
 Related subject(s) Neurology; Biology
  
65.Training — The Pharma Licensing Negotiation Master Class - with Dr. Roger Cox
 Dates 26 Jun 2014 → 27 Jun 2014
[ID=574575] Go to top of page
 LocationZurich (Opfikon-Glattbrugg), Switzerland
 Abstract Master the tools and skills to conclude the best financial deal when negotiating a licence agreement in the Pharma and Biotech sectors.
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-licensing-negotiation-course.html
 Contact Annelies Swaan, Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
66.2-day In-person Seminar on “Applied Statistics for QA, QC, Manufacturing, and Design Control” at Atlantic City NJ
 Dates 26 Jun 2014 → 27 Jun 2014
[ID=624086] Go to top of page
 LocationAtlantic City, United States
 Abstract This seminar provides a practical approach to understanding how to interpret and use a standard tool-box of statistical methods, including confidence intervals, t-tests, Normal K-tables, Normality tests, confidence/reliability calculations, AQL sampling plans, measurement equipment analysis, and Statistical Process Control. Without a clear understanding and correct implementation of such methods, a company risks significantly increasing its complaint rates, scrap rates, and time-to-market; and significantly reducing its product and service quality, its customer satisfaction levels, and its profit margins.
 Topics ISO and FDA regulations, Quality Assurance, Quality Control, MDD requirements, ComplianceOnline, Compliance Training
 Weblink http://bit.ly/1fQtq98
 Contact John Robinson ; Phone: [800-4479407]; Email: support@globalcompliancepanel.com
 Related subject(s) Probability and Statistics
  
67.ADMET — Enhancing drug quality by ADMET optimisation in discovery
 Dates 30 Jun 2014 → 01 Jul 2014
[ID=614617] Go to top of page
 LocationLondon, United Kingdom
 Abstract SMi’s established ADMET conference has been a premier event in its field for almost a decade. The 9th annual event taking place on 30th June and 1st July in central London, will bring together even more industry leading experts to deliver over eighteen case study driven presentations. A focal point for anyone working in the market for drug discovery and development, attending provides a unique forum to engage with KOL’s and experts active in the field
 Weblink http://www.smi-online.co.uk/goto/2014admet13.asp
 Contact Sajid Goraya; Phone: [020 7 827 6148]; Email: sgoraya@smi-online.co.uk
  
68.2nd Poorly Soluble Drugs Workshop — 2nd Poorly Soluble Drugs Workshop
 Start date02 Jul 2014
[ID=616024] Go to top of page
 LocationLille, France
 Abstract How to best formulate Poorly Water-Soluble Drugs
 Topics Poorly soluble drugs, Hot-melt extrusion, Spray-drying, Solubility measurements, Particle size measurements, Thermal analysis, Milling, Excipients, polymers, amorphous state, solid dispersions, drug delivery, formulation, Polyvinyl Acetate Phthalate, cyclodextrins
 Weblink http://apgi.org/2014_WS/
 Contact Catharina Kroling , APGI ; Phone: [+336293667]; Email: apgi.asso@u-psud.fr
  
69.Malaria Immunology and Vaccination
 Start date02 Jul 2014
[ID=559053] Go to top of page
 LocationLondon, United Kingdom
 Abstract This event will discuss the mechanisms of immunity and immunopathology in order to facilitate vaccine design and the identification of additional therapies for treatment of severe malaria. There will be plenty of opportunities for debate and networking.
 Weblink http://www.regonline.co.uk/ImmMal2014
 Related subject(s) Medicine (in general)
  
70.Forum MedTech Pharma
 Dates 02 Jul 2014 → 03 Jul 2014
[ID=623474] Go to top of page
 LocationNuremberg, Germany
 Abstract "MedTech Pharma 2014" is an international congress for researchers, developers, manufacturers, suppliers, service providers and clinical users of the medical and pharmaceutical industry. Every two years around 1000 experts are meeting in Nuremberg. The congress has advanced to one of the most important events for the healthcare industry. In high-level lectures innovative solutions and best practice examples will be presented and discussed. About 60 high level lectures parallel sessions, More than 100 exhibitors, International delegations, Job Wall, Evening rec
 Weblink http://www.medtech-pharma.de/english/congress/congress.aspx
  
71.RICT 2014 — Interfacing Chemical Biology and Drug Discovery
 Dates 02 Jul 2014 → 04 Jul 2014
[ID=623483] Go to top of page
 LocationMont-Saint-Aignan Cedex, France
 Abstract This major international symposium will gather more than 500 scientists from around the world. The scientific programme, which will include over 25 plenary lectures by internationally well-known scientists, focuses on " Interfacing Chemical Biology and Drug Discovery ", covering the main stages of modern drug discovery. The scientific committee ensures the high quality and diversity of the scientific programme together with the accessibility of the meeting to MSc and PhD students. For the latter, an advantageous registration fee will be proposed. Moreover, a special career session will be organised with industrial and academic participants. During the meeting the P. Ehrlich Lecture Award will be awarded to a researcher or a research team for his/their outstanding contribution to medicinal chemistry. In addition, a poster session will provide the opportunity for all participants to present their current results. A “best poster” prize will also be attributed.
 Weblink http://www.ldorganisation.com/v2/produits.php?langue=english&amp;cle_menus=1238915741&amp;cle_data=1360153389
 Related subject(s) Biochemistry and Medicinal Chemistry, Toxicology
  
72.Malaria Drug Development and Resistance Control
 Start date03 Jul 2014
[ID=571555] Go to top of page
 LocationLondon, United Kingdom
 Abstract The prevention of anti-malarial drug resistance is of enormous public health importance. It can be assumed that no therapy currently under development or to be developed in the foreseeable future will be totally protective against malaria. This event will discuss the development of new treatments for malaria together with the use of current drugs to limit, insofar as it is possible, any further development of resistance. There will be plenty of opportunity for delegates to present their work and network in an informal atmosphere, with a lot of time given for discussion and debate.
 Weblink http://www.regonline.co.uk/malariadrug2014
 Related subject(s) Medicine (in general)
  
73.EACPT focus meeting: 'Drugs to Fight Cardiovascular Damage'
 Dates 05 Jul 2014 → 09 Jul 2014
[ID=623457] Go to top of page
 LocationNijmegen, Netherlands
 Topics ultrasound imaging of vascular injury (including workshop to get hands-on training), microbioma and inflammation in metabolic syndrome, targeting inflammation to prevent and treat atherosclerosis, diagnosis and therapy of adrenal hypertension, protection against  ischemic-reperfusion injur
 Weblink http://www.eacpt.org/?q=node/98
 Related subject(s) Cardiology
  
74.Drug Metabolism — Integrating Drug Metabolism Sciences: From Enzymology to Systems Biology
 Dates 06 Jul 2014 → 11 Jul 2014
[ID=586768] Go to top of page
 LocationHolderness School, Holderness, NH, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Molecular Biology; Biochemistry and Medicinal Chemistry, Toxicology
  
75.LYO — Lyophilisation 2014
 Dates 07 Jul 2014 → 08 Jul 2014
[ID=613593] Go to top of page
 LocationLondon, United Kingdom
 Abstract SMi's 2nd annual Lyophilisation conference will provide an update on methodologies for lyophilisation and examine how to mitigate risks in production. Gain practical information and tools which you can use and apply in the workplace. Join our Lyophilisation forum and gain insight into current successes and challenges that leading pharma and biotech organisations are facing in the field. Evaluate ways in which to optimise your freeze-drying processes and product quality to assist you in your day-to-day role.
 Topics lyophilisation, Lyophilization cycle, freeze-drying, upscaling, stability, formulation, R&D, packaging, storage, cold storage, Chemical Engineering, pre-filled syringes, TDLAS, PAT, pharmaceutical storage, pharma packaging, protein formulation, vaccine, protein
 Weblink http://www.smi-online.co.uk/2014lyophilisation8.asp
 Contact Jonathan Collins , SMi Group Ltd ; Phone: [+44 (0)207 827 6734]; Email: jcollins@smi-onlinc.co.uk
 Related subject(s) Biotechnology
  
76.Natural Products, A celebration and a resurrection with Reverse Pharmacology
 Dates 07 Jul 2014 → 10 Jul 2014
[ID=624055] Go to top of page
 LocationBloomingdale, United States
 Weblink http://www.fusion-conferences.com/conference11.php
  
77.12th VAC — 12th Vaccines Research & Development: All Things Considered Conference
 Dates 09 Jul 2014 → 11 Jul 2014
[ID=619552] Go to top of page
 LocationBoston, United States
 Abstract GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline.
 Topics Vaccines
 Weblink http://www.gtcbio.com/conference/vaccines-research-and-development-overview?utm_source=vac conference&utm_medium=website&utm_content=vac overview&utm_campaign=conference listing
 Contact Kristen Starkey ; Phone: [(626) 256-6405]; Email: infogtcbio@gtcbio.com
  
78.Enabling Future Pharma
 Dates 09 Jul 2014 → 13 Jul 2014
[ID=624475] Go to top of page
 LocationBloomingdale, United States
 Abstract Non-profit organizations (NPO), including disease foundations, academia, independent research institutes, governmental agencies, etc., are uniquely positioned to develop targeted therapies for many of the rare and neglected diseases that are not actively pursued by the Big Pharma. Over the last 20 years, several of the FDA drug approvals for new Indications were from public sector research, thus affirming the NPOs leading role in finding cures for rare and neglected diseases. To provide a perspective on NPO operational models, the panel of experts and thought leaders from NPOs and pharma will engage in discussions spanning a broad range of scientific and business initiatives. The role of non-profits, including patient-based organizations, as catalysts in meeting the needs of patients and caregivers, and in the discovery and development of new drugs and biologics will be the overarching theme of this unique conference. Please join us in gaining critical insight in to how we can aid and foster future collaborations and drive bench to bedside innovations.
 Weblink http://www.fusion-conferences.com/conference17.php
  
79.11th Anti-infectives Partnering and Deal-Making Conference
 Dates 10 Jul 2014 → 11 Jul 2014
[ID=624434] Go to top of page
 LocationBoston, United States
 Abstract GTC’s Anti-Infectives Partnering & Deal Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry
 Weblink http://www.gtcbio.com/conference/anti-infectives-partnering-and-deal-making-overview
 Related subject(s) Medicine (in general)
  
80.41st Annual Meeting & Exposition of the Controlled Release Society
 Dates 13 Jul 2014 → 16 Jul 2014
[ID=624608] Go to top of page
 LocationChicago, United States
 Weblink http://www.controlledreleasesociety.org/meetings/annual/Pages/default.aspx
  
81.BOSS XIV - 14th Belgian Organic Synthesis Symposium
 Dates 13 Jul 2014 → 18 Jul 2014
[ID=624570] Go to top of page
 LocationLouvain-La-Neuve, Belgium
 Abstract The BOSS-conference is a unique international symposium as it combines lectures delivered by established organic chemists as well as younger rising stars with two prestigious events: a lecture delivered by the recipient of the “Janssen Pharmaceutica Prize for Creativity in Organic Synthesis”, and the “Tetrahedron Chair”: a one-day course on a specific topic in organic synthesis.
 Weblink http://www.boss14.org
 Related subject(s) Organic Chemistry and Polymers
  
82.Drug Resistance — An Interdisciplinary Approach to Tackling Drug Resistance Across Disease States
 Dates 13 Jul 2014 → 18 Jul 2014
[ID=586701] Go to top of page
 LocationNewry, ME, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Medicine (in general)
  
83.World Congress of Basic and Clinical Pharmacology
 Dates 13 Jul 2014 → 18 Jul 2014
[ID=624602] Go to top of page
 LocationCape Town, South Africa
 Abstract We have no doubt that the opportunity to connect with world leaders in pharmacology, industry and thought leaders in a memorable location defines WCP2014 as an event of scientific excellence not to be missed.
 Weblink http://www.wcp2014.org/
  
84.Immunogenicity
 Dates 14 Jul 2014 → 15 Jul 2014
[ID=624609] Go to top of page
 LocationLondon, United Kingdom
 Abstract SMi is launching its inaugural Immunogenicity Conference, taking place in London on the 14th and 15th July. This two day event is designed to enhance SMi’s portfolio of pharmaceutical conferences, especially with a growing demand for biologic therapeutics.
 Weblink http://www.smi-online.co.uk/immuno27.asp
  
85.Protein Processing, Trafficking & Secretion — Gordon Research Seminar/Insight into Molecular Mechanisms, Membrane Trafficking, Folding & ER Stress, Pathology and Therapeutic Applications
 Dates 19 Jul 2014 → 20 Jul 2014
[ID=588321] Go to top of page
 LocationColby-Sawyer College, New London, NH, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Molecular Biology
  
86.FBDD 2014 — Fragment-Based Drug Discovery Conference 2014
 Dates 19 Jul 2014 → 22 Jul 2014
[ID=609213] Go to top of page
 LocationPunta Cana, Dominican Republic
 Abstract Fragment based drug discovery is now widely recognized as an effective, multi-disciplinary approach to identifying highly efficient chemical matter for small molecule discovery programs. The approval of Zelboraf® has further highlighted how fragments can enable a program for rapid advancement, when effectively prosecuted. The maturation of FBDD has also spawned an explosion in the development and implementation of a host of biophysical tools that are utilized for both screening and characterization. Furthermore, the availability of protein-ligand structural information has provided insight into molecular interactions that are now routinely exploited in fragment optimization. The 2014 fragment based drug discovery conference will focus on state-of-the-art implementation of FBDD at all stages of small molecule identification and optimization. The agenda will feature a number of talks that focus on using FBDD to prosecute a wide array of protein target classes, as well as the implementation of biophysical tools for project enablement. The 2014 FBDD conference will be held at the beautiful Grand Palladium Resort & Spa where ZING’s unique conference format enables a congenial atmosphere highly conducive to extensive discussion and networking.
 Weblink http://www.zingconferences.com/conferences/fbdd/
 Contact Phone: [01223750020]; Email: matthew.kirkby@zingconferences.com
  
87.Protein Processing, Trafficking & Secretion — At the Crossroads of Understanding the Maturation and Transport of Proteins/Peptides and the Therapeutic Applications of Post-translational Modulation
 Dates 20 Jul 2014 → 25 Jul 2014
[ID=588300] Go to top of page
 LocationColby-Sawyer College, New London, NH, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Molecular Biology
  
88.Diffraction Methods in Structural Biology — Gordon Research Seminar/Towards Integrative Structural Biology
 Dates 26 Jul 2014 → 27 Jul 2014
[ID=586674] Go to top of page
 LocationBates College, Lewiston, ME, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Molecular Biology; Biology
  
89.Diffraction Methods in Structural Biology — Faster, Smaller, Better: Novel Technologies for Diffraction Experiments in Molecular Biology and Drug Discovery
 Dates 27 Jul 2014 → 01 Aug 2014
[ID=586642] Go to top of page
 LocationBates College, Lewiston, ME, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Molecular Biology; Biology
  
90.Medicinal Chemistry — Gordon Research Seminar/Explained and Applied
 Dates 02 Aug 2014 → 03 Aug 2014
[ID=587518] Go to top of page
 LocationColby-Sawyer College, New London, NH, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Biochemistry and Medicinal Chemistry, Toxicology
  
91.Medicinal Chemistry — The Leading Edge of Drug Discovery
 Dates 03 Aug 2014 → 08 Aug 2014
[ID=587519] Go to top of page
 LocationColby-Sawyer College, New London, NH, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Biochemistry and Medicinal Chemistry, Toxicology
  
92.ECI — Biological and Pharmaceutical Complex Fluids II: Novel Trends in Characterizing Interactions, Microstructure and Rheology
 Dates 10 Aug 2014 → 14 Aug 2014
[ID=616293] Go to top of page
 LocationDurham, United States
 Abstract Biotherapeutics or biologics are rapidly emerging as the next generation of therapeutic solutions for many life threatening diseases in the areas of unmet medical need. This sector is expected to continue its significant growth over the next decade as rapid development of recombinant proteins and peptides along with identification of newer targeting approaches lead to augmentation or replacement of small organic molecules with therapeutic proteins. Developing stable formulations with these biological complex fluids comes with its own set of challenges as complex specific and non-specific interactions can lead to self-association, irreversible aggregate formation, and other manifestations that negatively impact physicochemical properties and delivery. These in turn lead to issues in formulation storage stability, high viscosity and associated issues in manufacturing and injectability etc. Similar to other complex fluids, these biological complex fluids also exhibit rich interfacial and surface properties leading to structuring and interactions with air/water and solid/water interfaces.

Understanding and establishing the structure-property relationships in such systems and understanding interactions in complex biopharmaceutical formulations is, therefore, key to designing stable new therapeutic solutions and novel drug delivery mechanisms. However, most of these systems have their unique characterization challenges such as, small sample volumes, high sensitivity to any applied shear, external conditions etc. Also it is of primary importance to characterize the microstructure and interactions either in-vivo or in environments that very closely mimic the biological environment of interest. The need to characterize such complex fluids/soft matter systems also extends to other industrial sectors such as foods and some of the characterization challenges and limitations of current techniques remain quite similar across biopharmaceuticals & foods.

 Topics •Conformational and Colloidal Stability •Charge and Electrostatic Interactions •Protein-Protein Interactions •Protein Aggregation-Thermodynamics, Kinetics & Interactions •Protein Rheology and Microrheology in Bulk •Protein Structuring and Rheology at Interfaces •Micro/mesostructure in Self-Associated Biological Complex Fluids I
 Weblink http://www.engconf.org/conferences/biotechnology/biological-and-pharmaceutical-complex-fluids-ii-novel-trends-in-characterizing-interactions-microstructure-and-rheology/
 Contact Arlene Conway ; Phone: [12125146760]; Email: arlene@engconfintl.org
 Related subject(s) Applied Physics: Mechanics, Rheology and Tribology; Biology
  
93.ImVacS: The Immunotherapies and Vaccines Summit
 Dates 11 Aug 2014 → 13 Aug 2014
[ID=614590] Go to top of page
 LocationBoston, MA, United States
 Abstract ImVacS, The Immunotherapies and Vaccine Summit, brings together a global audience of vaccine researchers and developers of cancer immunotherapies for four focused meetings that explore the frontiers of immunology as the basis for patient treatment.

Part 1 of the 9th annual "Novel Vaccines" meeting addresses "Adjuvants, TLRs and DNA Vaccines," while Part 2 explores "Emerging Vaccine Technologies." The 2nd annual "Immunomodulatory Therapeutic Antibodies for Cancer" meeting examines developments in the models and tools used in developing these emerging drug products, while the inaugural "Combination Cancer Immunotherapy" meeting focuses on the application of these antibody programs in combination with other treatment modalities. Target Discovery for T Cell Therapy Symposium will bring together leading academic and industry researchers to discuss how to find and validate suitable targets and antigens for t cell therapies.

 Topics vaccine, immunotherapies, immunology, t cell, cancer, adjuvant, tlr, antibody, therapeutic antibodies, therapeutics
 Weblink http://www.imvacs.com
 Contact Kris Waterman; Phone: [781-972-5400]; Email: kwaterman@healthtech.com
  
94.ImVacS: The Immunotherapies and Vaccines Summit
 Dates 11 Aug 2014 → 14 Aug 2014
[ID=624897] Go to top of page
 LocationBoston, United States
 Abstract ImVacS, The Immunotherapies and Vaccine Summit, brings together a global audience of vaccine researchers and developers of cancer immunotherapies for four focused meetings that explore the frontiers of immunology as the basis for patient treatment.   Part 1 of the 9th annual "Novel Vaccines" meeting addresses "Adjuvants, TLRs and DNA Vaccines," while Part 2 explores "Emerging Vaccine Technologies." The 2nd annual "Immunomodulatory Therapeutic Antibodies for Cancer" meeting examines developments in the models and tools used in developing these emerging drug products, while the inaugural "Combination Cancer Immunotherapy" meeting focuses on the application of these antibody programs in combination with other treatment modalities. Target Discovery for T Cell Therapy Symposium will bring together leading academic and industry researchers to discuss how to find and validate suitable targets and antigens for t cell therapies.
 Weblink http://www.imvacs.com/
  
95.Drug Carriers in Medicine & Biology — Gordon-Merck Research Seminar
 Dates 16 Aug 2014 → 17 Aug 2014
[ID=586703] Go to top of page
 LocationWaterville Valley, NH, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Molecular Biology
  
96.Drug Carriers in Medicine & Biology — Leveraging Mechanism and Chemical Design for Improved Therapeutic Effect
 Dates 17 Aug 2014 → 22 Aug 2014
[ID=586726] Go to top of page
 LocationWaterville Valley, NH, United States
 Organizer Gordon Research Conferences
 Weblink http://www.grc.org/meetings.aspx?year=2014
 Related subject(s) Molecular Biology
  
97.GA 2014 — 62nd International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research
 Dates 31 Aug 2014 → 04 Sep 2014
[ID=612060] Go to top of page
 LocationUniversity of Minho, Guimaraes, Portugal
 Abstract The Society for Medicinal Plant and Natural Product Research (GA) invites all scientists from academia and industry dealing with natural products, medicinal plants and phytotherapy, to this congress. GA2014 is a forum for the presentation and discussion of the latest research in the fields of phytochemistry, analytics, pharmacology and clinical applications. The conference will provide a platform for networking between academia and industry.
 Topics Clinical phytomedicine, Nanotechnology and drug delivery, Natural compounds as leads, Natural products from fungi and algae, Nutritional phytochemicals, Medicinal plants and bioeconomy, Metabolomics, Plant molecular farming
 Weblink http://ga2014.bio.uminho.pt/
 COMS online registration https://www.conference-service.com/ga2014/welcome.cgi
 Related subject(s) Biology; Medicine (in general)
  
98.DD 2.0 — ECCB workshop: Drug Development 2.0 -- Computational drug repurposing, target discovery and translational research.
 Start date07 Sep 2014
[ID=624155] Go to top of page
 LocationStrasbourg, France
 Abstract The discovery of differentiated new medicines that provide clear benefits to patients remains challenging in spite of ever increasing investments. At the same time the quantity and diversity of patient related data continues to grow exponentially (pre-clinical data, clinical data, patient data, EHR, ‘OMICs data, and information associated with medicines in general). New business models are also emerging with stronger collaborations between the industry and the academia with large public private partnerships (PPPs such as IMI in the EU) or the use of crowd sourcing. The scientific community is starting to leverage this wealth of information in ways that have the potential to disrupt the traditional drug discovery and development process as we know it. This workshop also invites submissions that leverage and translate similar techniques and data sets to new application domains including Health Outcomes Research, Biotech and Agriculture.
 Topics computational drug repurposing and repositioning, target identification, drug development, bioinformatics, computational biology, systems biology
 Weblink http://www.eccb14.org/program/workshops/dd
  
99.Regulatory Affairs — 4th International Conference on Pharmaceutical Regulatory Affairs
 Dates 08 Sep 2014 → 10 Sep 2014
[ID=610694] Go to top of page
 LocationNorth Carolina, United States
 Weblink http://regulatoryaffairs2014.pharmaceuticalconferences.com/
 Contact Kasper Dave; Phone: [1-650-268-9744]; Email: regulatoryaffairs2014@omicsgroup.us
  
100.GCC Pharmaceutical Congress
 Dates 14 Sep 2014 → 17 Sep 2014
[ID=614016] Go to top of page
 LocationDubai, United Arab Emirates
 Abstract Pharmacists play an important role as leaders to improve healthcare outcomes, decrease cost, reduce patient safety risk, optimize medication management system and align the pharmacy services with the management strategies that measure and reward quality performance. However, the continuing evolution of pharmacist role is tied to numerous challenges including collaboration with the different stakeholders in the medical community, learning about new technologies, remaining competitive in the market place, improving patient outcomes, maintaining productivity and more.
 Weblink http://gccpharmacongress.com/
 Contact Negin Bagherian; Phone: [+971 4 3619616]; Email: negin.bagherian@maarefah-management.org
  
101.ECI — Particulate Processes in the Pharmaceutical Industry IV
 Dates 14 Sep 2014 → 18 Sep 2014
[ID=617664] Go to top of page
 LocationPotsdam, Germany
 Abstract Over 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; high-shear granulation; fluidized bed drying, granulation, and coating; tablet compaction; fine powder transport, mixing, and blending. These and other particulate processes are used for the large-scale manufacture of tablets and capsules for public consumption. As such, efficient handling and processing of particulates is critical to meeting the stringent guidelines set by the FDA and profitable manufacture of pharmaceutical products. Failed batches can mean the loss of hundreds of thousands of dollars in revenue needed to payback the tremendous up-front investment that is inherent in drug development. A recent US-FDA report on the pharmaceutical industry estimated that worldwide cost savings from manufacturing improvements could be as high as US$ 90 billion per year.

Particulate-based manufacturing processes need to be better understood so that they can be properly controlled and scaled up. The last decade has seen a shift from empirical formulation efforts to an engineering approach based on a better understanding of particulate behaviours in the process, facilitated by technological advances in computer modelling, manufacture and measurement techniques.

 Topics Crystallization and Formulation Engineering Novel Drug Delivery Systems Manufacture Processes and Product Engineering Simulation and Modelling Predictive Modelling, Design Space and Process Analytic Technology
 Weblink http://www.engconf.org/14AN
 Contact Arlene Conway ; Phone: [12125146760]; Email: arlene@engconfintl.org
  
102.Polymers in Drug Delivery
 Dates 16 Sep 2014 → 17 Sep 2014
[ID=612293] Go to top of page
 LocationPhiladelphia, United States
 Abstract The event focuses on parenteral drug administration (PDA), i.e. non-oral routes of pharmaceutical delivery including pre-filled syringes, bags, tubes, inhalers, and implants that leach active ingredients.
 Weblink http://www.amiplastics-na.com/events/Event.aspx?code=C613&sec=4246
 Contact Stephanie Berchem; Phone: [610 478 0800]; Email: sb@amiplastics-na.com
 Related subject(s) Organic Chemistry and Polymers
  
103.BDT2014 — 3rd Biomarkers in Diagnostics & Therapeutics
 Dates 24 Sep 2014 → 25 Sep 2014
[ID=621142] Go to top of page
 LocationSingapore, Singapore
 Abstract BDT2014 looks at market outlooks and industry trends for biomarker diagnostics, technologies and services. The theme - Catalysing the Paradigm Shift in Healthcare - locks the conference focus on the diagnostic and therapeutic potentials of novel disease biomarkers and how innovations in technology platform capability enables applications that go towards fuelling transformations of the healthcare sector.
 Topics Biomarkers, Diagnostics, Therapeutics, Healthcare, Chronic diseases, Cancer, Cardiovascular, CNS, Neurology
 Weblink http://www.astrikevents.com/BDT2014.php
 Contact Phone: [+65 6853 9156]; Email: enquiry@astrikevents.com
  
104.4th International Conference on Vaccines & Vaccination
 Dates 24 Sep 2014 → 26 Sep 2014
[ID=610717] Go to top of page
 LocationValencia, Spain
 Abstract This meeting will be the latest in a series of successful annual vaccine meetings organized by the OMICS Group Conference that seek to bring together vaccine stakeholders including academic researchers, public health clinicians, vaccine policy makers, corporates and vaccine manufacturers. In association with the Vaccines-2014 meeting there will be opportunities for those selected to present at the meeting to also publish a manuscript from their talk in the Journal of Vaccines and Vaccination or its sister publication Immunome Research.
 Topics Vaccine adjuvants, Veterinary vaccines, Therapeutic vaccines for chronic infections, Cancer vaccines, Biodefense vaccine, AIDS vaccine, Vaccine antigen modeling, Immuno-informatics in vaccine design, Vaccine formulation issues, Unconventional vaccines
 Weblink http://www.omicsgroup.com/vaccines-vaccination-conference-2014/
 Contact Phone: [650-268-9744]; Email: vaccines2014@omicsonline.net
  
105.GMP Summi-2014 — 3rd International Summit on GMP, GCP & Quality Control
 Dates 25 Sep 2014 → 26 Sep 2014
[ID=571801] Go to top of page
 LocationValencia, Spain
 Abstract This year the annual conference will provide an A to Z perspective of the pharmaceutical production process from API to formulated product. The performance of the pharmaceutical production cannot be improved significantly if you do not look at it holistically. The main theme of the conference is “Manufacturing and Quality Guidelines; Training and Beyond”.
 Topics GMP, GCP, GLP, QA, QC, VALIDATION, CLINICAL TRIALS, REGULATORY AFFAIRS
 Weblink http://www.pharmaceuticalconferences.com/gmp-gcp-quality-control-2014/
 Contact Victor Oliver ; Phone: [888-843-8169]; Email: gmpsummit2014@omicsonline.net
 Related subject(s) Clinical trials
  
106.Orphan Drugs — Orphan Drugs, Collaborations & Market Access Congress
 Dates 29 Sep 2014 → 30 Sep 2014
[ID=612951] Go to top of page
 LocationSan Diego, United States
 Abstract The congress will bring together investors and experts in the orphan drug and rare disease space to share innovative research and best practice approaches to issues in R&D, clinical development, market access, pricing and reimbursement. Through an expert speaker panel, interactive forums, and a vibrant exhibition area, the meeting hopes to create long-lasting partnerships and solutions that help to address both the 7,000 rare diseases afflicting patients, market access challenges and opportunities and the financial implications of working in this field.
 Topics Orphan Drugs, drug, discovery, R & D, research, market access, therapies, patient, investment, venture capital
 Weblink http://www.globalengage.co.uk/orphan-drugs.html
 Contact Phone: [0186 584 9841]; Email: nnoakes@globalengage.co.uk
  
107.Course — Organic Process Research & Development
 Dates 29 Sep 2014 → 01 Oct 2014
[ID=568522] Go to top of page
 LocationCologne, Germany
 Organizer Scientific Update LLP
 Weblink http://www.scientificupdate.co.uk/conferences/conferences-and-workshops.html
  
108.BABE-2014 — 5th World Congress on Bioavailabity and Bioequivalence: Pharmaceutical R&D Summit
 Dates 29 Sep 2014 → 01 Oct 2014
[ID=605067] Go to top of page
 LocationBaltimore, United States
 Abstract BABE-2014 is a scientific avenue for people from diversified Pharmaceutical backgrounds, Academic Institutions, Healthcare Institutes, Pharmaceutical Regulatory Agencies, Biotech and Clinical Research Organizations making the congress a desirable platform where participants can communicate and mutually get benefited by sharing experiences about their respective fields of interest, build collaborations with research organizations, acquire benefits from interactive workshops, promote innovative styles, trends and advancements of Bioavailability and Bioequivalence.
 Weblink http://babe2014.pharmaceuticalconferences.com/
 Contact John Benson , BABE-2014 Organizing Committee ; Phone: [1-888-843-8169]; Email: babe2014@omicsonline.us
  
109.The 5th Asia Clinical Triials Outsourcing Congress
 Dates 09 Oct 2014 → 10 Oct 2014
[ID=599558] Go to top of page
 LocationSan Diego, United States
 Abstract This conference combines the previously independent China Clinical Trials Outsourcing Congress and Asia Clinical Trials Outsourcing Congress to address the subjects relevant to the region in a more coherent way. It is also co-located with the Asia Pharma R&D Outsourcing Congress which will look at the growing trend towards conducting earlier phases of discovery and pre-clinical studies in Asia.
 Topics Clinical Trials, CROS, Pharmacovigilence, Outsourcing
 Weblink http://www.clinical-trials-events.com/asia.html
 Contact Nick Noakes; Phone: [+44 (0) 1865 849841]; Email: nnoakes@globalengage.co.uk
 Related subject(s) Clinical trials
  
110.MedicReS 4th World Congress on Good Medical Research
 Dates 16 Oct 2014 → 18 Oct 2014
[ID=575498] Go to top of page
 LocationNew York, United States
 Weblink http://www.medicres.org
 Contact Burak AKICIER; Email: info@medicres.org
 Related subject(s) Medicine (in general)
  
111.World Pharma Trials Korea 2014
 Dates 21 Oct 2014 → 23 Oct 2014
[ID=612697] Go to top of page
 LocationSeoul, South Korea
 Abstract Pharma Trials World Korea is where international and regional pharma companies, trial sponsors, CROs and clinical trial sites gather to strategise in accelerating clinical development, accessing emerging markets, enhancing clinical operations through effective offshoring and outsourcing in Korea. Join senior level attendees from international pharma companies looking to obtain regulatory data for products in Korea and companies trying to optimize drug clinical development. Tap into the Korea's pharma market by partnering with CROs and clinical trial sites.
 Topics How to overcome regulatory challenges in Korea, How to integrate their clinical trial studies in Korea with their global development plan, How to effectively design clinical trial operation strategies in a most cost-efficient manner, How to accelerate clinical development cycles using the latest analytical and statistics tools, How to select the right CROs as partners who can deliver quality and results, How to choose a reliable clinical trial supply partner in Korea
 Weblink http://www.terrapinn.com/conference/pharma-trials-world-korea/index.stm
 Contact Rebecca Koh , Terrapinn Pte Ltd ; Phone: [+65 6322 2725]; Email: rebecca.koh@terrapinn.com
 Related subject(s) Clinical trials
  
112.Stem Cells Regenerative Medicine Congress Asia
 Dates 21 Oct 2014 → 23 Oct 2014
[ID=612674] Go to top of page
 LocationSeoul, Singapore
 Abstract Stem Cells & Regenerative Medicine Congress Asia 2014 brings together leading pharmas, biotechs, regulators, research institutes and investors from Asia and beyond to unveil key strategies for commercialising a stem cell based therapy, streamlining clinical development, navigating the regulatory landscape and gaining funds to expedite innovative R&D efforts. This conference is co-located with Cell Culture World Asia.
 Topics stem cells, regenerative medicine, congress, asia, clinical development, cell culture, pharma, biotech
 Weblink http://www.terrapinn.com/2014/stem-cells-regenerative-medicine-asia-congress/index.stm
 Contact Rebecca Koh , Terrapinn Pte Ltd ; Phone: [+65 6322 2725]; Email: rebecca.koh@terrapinn.com
  
113.VACC14 — 8th Vaccine & ISV Congress
 Dates 26 Oct 2014 → 28 Oct 2014
[ID=612930] Go to top of page
 LocationPhiladelphia, United States
 Abstract Join us in Philadelphia for the premier conference on vaccines and vaccination. The 8th Vaccine & ISV Congress will feature science and public health topics, from primary vaccine research and vaccine manufacturers, to governmental policy, safety and regulation. If you work as a researcher in vaccine-related topics, in the vaccine industry, or in vaccine policy making, this is your must-attend event in 2014.
 Topics Human vaccines - infectious diseases, Human vaccines - non-infectious diseases, Veterinary vaccines, Vaccine safety, Clinical studies and field trials, Immunology, animal models, Vectors, adjuvants, drug delivery, Production, manufacturing, Regulatory, societal, economic, programmatic, legislation subjects
 Weblink http://www.vaccinecongress.com/
  
114.8th Alpine Meeting: Current & Future challenges of oncology drug development
 Dates 29 Oct 2014 → 31 Oct 2014
[ID=624282] Go to top of page
 LocationTelfs-Buchen/Innsbruck, Austria
 Abstract Meeting between experts from academia, regulatory authorities and pharmaceutical industry to discuss the latest challenges in oncology drug development. Some topics discussed at the Alpine Meeting will lead to workshops over the year.
 Topics Cancer, Oncology, Drug Development, Biomarkers for Immunotherapies, Adaptive Licensing, Breakthrough Therapies, Cross over in registration studies, Progression-free survival, Impact on genomic instability for future anti-cancer drug development, Improving oncology drug development for children and adolescents
 Weblink http://www.bdaoncology.org/pages/pv.asp?p=bda71
 Contact Marjorie Recorbet ; Phone: [+32 27750215]; Email: marjorie.recorbet@ecco-org.eu
 Related subject(s) Oncology
  
115.Alterations in the Immune System in Smokers
 Start date05 Nov 2014
[ID=571510] Go to top of page
 LocationLondon, United Kingdom
 Abstract Inflammatory processes and changes in the immune system are crucial in the pathogenesis of smoking related disorders and many of these immunological changes are not completely reversible after smoking cessation. This event will discuss how the immune system is altered will smoking and address the consequences of these changes and ways to reverse them.
 Weblink http://www.regonline.co.uk/ImmSmoke2014
 Related subject(s) Medicine (in general)
  
116.CHEMOTHERAPY FOUNDATION SYMPOSIUM: Innovative Cancer Therapy for Tomorrow®
 Dates 05 Nov 2014 → 07 Nov 2014
[ID=623122] Go to top of page
 LocationNew York, United States
 Abstract CHEMOTHERAPY FOUNDATION SYMPOSIUM, Innovative Cancer Therapy for Tomorrow®, is a CME accredited educational activity jointly presented by the Icahn School of Medicine at Mount Sinai and the Chemotherapy Foundation, a non-profit organization supporting cancer research, in collaboration with The Tisch Cancer Institute. Founded in 1972 by Ezra Greenspan, we continue to bring the groundbreaking advances spearheading progress in cancer therapeutics to community and academic practitioners. Leading oncologist and hematologist investigators will report on new regimens, clinical trials and emerging therapeutic advances in common cancer types.
 Topics Cancer, Chemotherapy, Oncology, Hematology, Breast Cancer, Gynecological Oncology, Surgical Oncologists, Pediatric Oncology, Radiotherapy, Immunology, Oncology Nurses, Case Managers, Pharmacists
 Weblink http://www.chemotherapyfoundationsymposium.org/CMS/
 Contact Phone: [212 866 2813]; Email: Jaclyn.silverman@mssm.edu
 Related subject(s) Oncology; Hematology
  
117.Developing protein therapeutics for heart failure
 Start date07 Nov 2014
[ID=578761] Go to top of page
 LocationLondon, United Kingdom
 Abstract This event will discuss novel therapeutic concepts to both prevent and combat heart failure, including therapeutics which may be used to directly promote cardiac repair and even regeneration.
 Weblink https://www.regonline.co.uk/TheraHeart2014
 Related subject(s) Cardiology
  
118.Transfer of Analytical Methods for Pharmaceutical Analysis
 Start date07 Nov 2014
[ID=619550] Go to top of page
 LocationLondon, United Kingdom
 Abstract Transferring an analytical method from one laboratory to another should be straightforward but unfortunately it is a process which is often problematic. Recognition of this has resulted in a new USP chapter <1224> and an update to chapter 6 of the EU GMP regulations. In this one day course the different approaches to transfer are explored fully and case studies are used extensively to follow the process from review of the method prior to transfer, to creating a suitable protocol with relevant acceptance criteria, and evaluating the results generated to assess whether the transfer has been successful.
 Topics Method transfer, analytical method transfer, pharmaceutical method transfer
 Weblink http://www.mournetrainingservices.co.uk/course_list.html
 Contact Oona McPolin; Phone: [+44 (0) 28 417 73724]; Email: info@mournetrainingservices.co.uk
  
119.7th Medication Safety Conference 2014
 Dates 07 Nov 2014 → 09 Nov 2014
[ID=621980] Go to top of page
 LocationAbu Dhabi, United Arab Emirates
 Abstract Based on the sound success of previous Medication Safety Conferences, the 7th Medication Safety Conference expects to attract over 1000 delegates devoted to Patient safety and in particular, medication safety best practices. Featuring an exhibition showcasing the latest in pharmaceutical advancements and innovations, the conference will be a ground for interaction for healthcare professionals, including, but not limited to; pharmacists, medical and nursing staff, hospital management, healthcare quality professionals and pharmaceuticals industry.
 Topics Pharmacy Practice, Medication safety
 Weblink http://medicationsafetyconference.com/
 Contact Phone: [00971 2 4434331]; Email: info@synovetics.com
 Related subject(s) Medicine (in general)
  
120.Innate Immunity Interactions with Pathogens
 Start date10 Nov 2014
[ID=571542] Go to top of page
 LocationLondon, United Kingdom
 Abstract Infectious disease are still a major cause of morbidity and mortality worldwide. Innate immunity is of paramount importance for the control of pathogens in the early stages of the infection and for the engenderment and expansion of acquired immunity. This EuroSciCon meeting will be a premier forum for the presentation of cutting-edge research on how the interaction between innate immune mechanisms and pathogens impacts on host resistance, immunoevasion, immunodeficiencies and vaccine efficacy.
 Weblink http://www.regonline.co.uk/innatepath2014
 Related subject(s) Medicine (in general); Molecular Biology
  
121.Investigating interactions of the Innate and Adaptive Immune Systems
 Start date11 Nov 2014
[ID=571530] Go to top of page
 LocationLondon, United Kingdom
 Abstract The cells of the innate immune system play a crucial part in the initiation and subsequent direction of adaptive immune responses. The event will discuss this role of the innate immune system, drawing on new research and the opportunity for networking and informal discussion.
 Weblink http://www.regonline.co.uk/innateadapt2014
 Related subject(s) Medicine (in general); Molecular Biology
  
122.Therapeutic applications of the Innate Immune system
 Start date12 Nov 2014
[ID=571572] Go to top of page
 LocationLondon, United Kingdom
 Abstract The identification of antigen recognition receptors for innate immunity has sparked great interest in therapeutic manipulation of the innate immune system. For example Toll-like receptor agonists are being developed for the treatment of cancer, allergies and viral infections, and as adjuvants for cancer and disease vaccines. This event will explore current research and applications of the innate system for therapeutic applications. There will be plenty of opportunity for discussion and debate and we encourage submission of abstracts for both oral and poster presentation.
 Weblink http://www.regonline.co.uk/innatethera2014
 Related subject(s) Medicine (in general)
  
123.Kurs — Pharmarecht für Laborleiter und QM-Beauftragte
 Start date13 Nov 2014
[ID=608918] Go to top of page
 LocationKoblenz, Germany
 Organizer NOVIA GmbH
 Abstract Welche Zulassungsvoraussetzungen muss der pharmazeutische Hersteller erfüllen? Welche regulatorischen Hürden müssen bei einer Änderung (Change Control) im Qualitätsbereich überwunden werden? Antworten auf diese Fragen werden im Rahmen dieses Seminares beantwortet. Gleichzeitig liegt ein Schwerpunkt des Seminares bei der Frage, welche Haftung der Laborleiter auch für das Fehlverhalten seiner Mitarbeiter übernimmt und welche Wege es aus der Haftung gibt.
 Topics Pharma, Recht, Pharmarecht, QM, Qualitätsmanagement
 Weblink https://www.novia.de/
 Contact NOVIA GmbH, Frankfurt; Phone: 069 305 43843; Email: info@novia.de
  
124.BioPharma India Convention 2014
 Dates 18 Nov 2014 → 19 Nov 2014
[ID=610700] Go to top of page
 LocationMumbai, Singapore
 Abstract BioPharma India Convention is uniquely positioned as India’s only event where global and regional pharma and biotech companies, CMOs, CROs, investors and other pharma stakeholders come together to assess the latest trends, partnerships and solutions across the pharma value chain in India. The event includes: an international exhibition, one-to-one meeting sessions and an online networking system.
 Topics partnership, networking, exhibition
 Weblink http://www.terrapinn.com/conference/biopharma-india/index.stm
 Contact Rebecca Koh , Terrapinn Pte Ltd; Phone: [+65 6322 2725]; Email: rebecca.koh@terrapinn.com
  
125.EORTC-NCI-AACR 2014 — 26th EORTC-NCI-AACR Symposium on 'Molecular Targets and Cancer Therapeutics'
 Dates 18 Nov 2014 → 21 Nov 2014
[ID=578381] Go to top of page
 LocationBarcelona, Spain
 Abstract The Symposium presents a unique opportunity to meet with academics and scientists in the field of drug discovery and targets in cancer all under one roof. A presence at this event also helps to raise the profile of your organisation and brand as well as generate new opportunities with suppliers and other organisations who are exhibiting at the symposium.
 Topics drug development, target selection, molecular biology, cancer therapeutics, molecular targets
 Weblink http://www.ecco-org.eu/ENA2014
 Contact Phone: [+32 2 775 0201]; Email: ena2014@ecco-org.eu
 Related subject(s) Oncology; Molecular Biology
  
126.Clinical Pharmacy-2014 — 2nd International Summit on Clinical Pharmacy
 Dates 02 Dec 2014 → 03 Dec 2014
[ID=613127] Go to top of page
 LocationSan Francisco, United States
 Abstract Clinical Pharmacy-2014 is a unique event which forms a network with leading pharmacy doctors, researchers, industry professionals, scientists, pharmacists and scholar students to exchange and share their experiences, new ideas and research results about all aspects of Clinical Pharmacy and to discuss the practical challenges encountered and the solutions adopted.

2nd International Summit on Clinical Pharmacy provides opportunities for the delegates to exchange new ideas and new application experiences directly, to establish research relations and to find global partners for future collaboration. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies about Clinical Pharmacy. By attending this prestigious event you will be enlightened with innovative ideas and solutions and take initiatives to find better education in the biomedical, pharmaceutical, sociobehavioral and clinical sciences.

 Topics General Clinical Pharmacology, Pharmacists Role in Patient Safety, Clinical Pharmacy and Its Key Role in Treatment, Dispensing Pharmacy and Research Chemists
 Weblink http://clinicalpharmacy2014.pharmaceuticalconferences.com/index.php
 Contact Phone: [1-650-268-9744]; Email: clinicalpharmacy2014@omicsgroup.us
  
127.Transfer of Analytical Methods for Pharmaceutical Analysis
 Start date05 Dec 2014
[ID=619626] Go to top of page
 LocationBerlin, Germany
 Abstract Transferring an analytical method from one laboratory to another should be straightforward but unfortunately it is a process which is often problematic. Recognition of this has resulted in a new USP chapter <1224> and an update to chapter 6 of the EU GMP regulations. In this one day course the different approaches to transfer are explored fully and case studies are used extensively to follow the process from review of the method prior to transfer, to creating a suitable protocol with relevant acceptance criteria, and evaluating the results generated to assess whether the transfer has been successful.
 Topics Method transfer, analytical method transfer, pharmaceutical method transfer
 Weblink http://www.mournetrainingservices.co.uk/course_list.html
 Contact Oona McPolin; Phone: [+44 (0) 28 417 73724]; Email: info@mournetrainingservices.co.uk
  

Last updated: 23 April 2014